
Maximilian Konig MD
Rheumatology
Assistant Professor of Medicine; Director, Cellular Therapy Program (Autoimmunity)
Join to view full profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Konig is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Maximilian Konig is a board-certified internist and rheumatologist affiliated with Johns Hopkins Hospital in Baltimore, MD. He received his medical degree from Charité - Universitätsmedizin Berlin and completed his residency training in Internal Medicine at Massachusetts General Hospital, Harvard Medical School. Dr. Konig concluded fellowship training in Clinical and Molecular Rheumatology as well as Advanced Rheumatology at Johns Hopkins Hospital.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2020 - 2021
Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2019 - 2021
Johns Hopkins UniversityFellowship, Rheumatology, 2018 - 2020
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2017 - 2018
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2016 - 2017
Certifications & Licensure
MD State Medical License 2019 - 2026
MA State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow, American College of Physicians 2022
- Jerome L. Greene Foundation Scholar 2021
- Distinguished Fellow Award American College of Rheumatology, 2021
Clinical Trials
- Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) Start of enrollment: 2020 May 13
Publications & Presentations
PubMed
- Lethal toxin-equipped effector cells for the potential treatment of cancer.Alexander H Pearlman, Brian J Mog, Michael S Hwang, Jordina Rincon-Torroella, Sarah R DiNapoli
Proceedings of the National Academy of Sciences of the United States of America. 2026-03-24 - 1 citationsBiodegradable targeted polymeric mRNA nanoparticles enable in vivo CD19 CAR T cell generation and lead to B cell depletion.Manav Jain, Savannah E Est-Witte, Sydney R Shannon, Sarah Y Neshat, Xinjie Yu
Science Advances. 2026-03-13 - Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.Sarah R DiNapoli, Katharine M Wright, Brian J Mog, Alexander H Pearlman, Tushar D Nichakawade
The Journal of Clinical Investigation. 2026-01-16
Journal Articles
- COVID-19 outcomes among hospitalized men with or without exposure to alpha-1-adrenergic receptor blocking agentsLi S, Jun T, Wang Z, Kao YH, Schadt E, Konig MF, Bettegowda C, Vogelstein JT, Papadopoulos N, Parsons RE, Chen R, Schadt EE, Li L, Oh WK, medRxiv, 2021
- The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19Rose L, Graham LA, Koenecke A, Powell M, Xiong R, Shen Z, Kinzler KW, Bettegowda C, Vogelstein B, Konig MF, Athey S, Vogelstein JT, Wagner TH, medRxiv, 12/22/2020
- Digit Ulcerations in a Young WomanMaximilian Konig, MD, JAMA
Authored Content
- A 37-year-old woman with lupus and pneumoniaApril 2022
- A 57-year-old woman with new-onset hypertensionFebruary 2022
- A 74-year-old man with acute onset of fevers, headaches, and neck painDecember 2021
Press Mentions
New Breakthroughs in Autoimmune Disease Treatment: CAR-T, mRNA & MoreNovember 14th, 2025
Researchers Try Bold New Approach in a Race to Better Treat Autoimmune DiseasesNovember 13th, 2025
Rheumatologists Face Challenges in Identifying High-Quality COVID-19 LiteratureAugust 28th, 2020
Committees
- Member, American College of Rheumatology, Early Career Investigator Subcommittee 2022 - Present
- Member, American College of Rheumatology, Abstract Oversight Subcommittee 2021 - Present
- Member, American College of Rheumatology, ACR-Food and Drug Administration Summit Organizing Committee 2021 - 2021
- Fellow-in-Training Member, American College of Rheumatology, Committee on Research 2020 - 2021
- Member, COVID-19 Global Rheumatology Alliance, Clinical Advisory Sub-Committee 2020 - 2021
Professional Memberships
- Fellow
- Member
- Fellow
- German National Academic FoundationFellow
- The Federation of Clinical Immunology Societies - FOCISMember
Other Languages
- German
External Links
- Homepagehttps://www.hopkinsmedicine.org/profiles/details/maximilian-konig
- Lab Websitehttp://www.koniglab.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









